TIL Q3 2021 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$60M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$43M

Net Income

-$43M

EPS (Diluted)

$-0.33

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$51M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$647M

Total Liabilities

$46M

Stockholders' Equity

$601M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$52,000	-100.0%
Gross Profit	$0	$52,000	-100.0%
Operating Income	-$43M	-$8M	-458.0%
Net Income	-$43M	-$7M	-492.2%